Validations: Container/Closure Qualification & Seal Integrity
Closure Component Variability: Lots, Suppliers, and Controls Closure Component Variability: Lots, Suppliers, and Controls Introduction to Extractables and Leachables in Pharmaceutical Packaging In the pharmaceutical industry, ensuring the integrity and safety of drug products is paramount. One critical aspect of this assurance revolves around packaging systems, particularly concerning extractables and leachables (E&L). E&L can directly impact the efficacy and safety…
Visual Inspection and CCI: Complementary, Not Redundant Visual Inspection and CCI: Complementary, Not Redundant Introduction to Extractables and Leachables (E&L) The pharmaceutical industry has strict regulations surrounding the quality and safety of drug products, particularly when it comes to extractables and leachables (E&L). These compounds can originate from packaging materials, specifically the container closure systems, and can impact the quality…
Parametric Release Environments: CCI Considerations Parametric Release Environments: CCI Considerations Introduction to Extractables and Leachables In the pharmaceutical industry, ensuring the safety and efficacy of drug products is paramount. A critical aspect of this assurance is understanding extractables and leachables (E&L), especially in the context of packaging components and container systems. E&L refers to the chemical substances that can migrate…
Change Control: When to Re-Validate CCI Change Control: When to Re-Validate CCI Introduction to Change Control and Container Closure Integrity Change control is a critical component in the pharmaceutical industry, especially concerning Container Closure Integrity (CCI). Maintaining the integrity of packaging systems is essential for ensuring the quality and safety of pharmaceutical products throughout their lifecycle. Regulatory expectations from bodies…
Trending CCI Failures: False Rejects vs True Leakers Trending CCI Failures: False Rejects vs True Leakers In the realm of pharmaceutical packaging, ensuring the safety and integrity of drug products is paramount. One critical aspect is maintaining container closure integrity (CCI), particularly amidst increasing reliance on extractables and leachables (E&L) risk assessments. In this tutorial, we will explore trending CCI…
Packaging Line Qualification: Setup, Speeds, and Reconciliation The qualification of packaging lines is a critical component in the pharmaceutical manufacturing process, particularly when ensuring compliance with regulations regarding extractables and leachables (E&L). This comprehensive guide aims to provide pharmaceutical professionals with an essential understanding of packaging line qualification, including setup, operational speeds, and reconciliation practices in line with US FDA,…
Residual Seal Force (RSF) and Seal Strength: Interpreting Results Understanding Residual Seal Force (RSF) and Its Importance in Container Closure Integrity Residual Seal Force (RSF) is a critical parameter in ensuring the integrity of pharmaceutical packaging systems. It refers to the force that remains on a sealed container after the sealing process is complete. This force plays a pivotal role…
Aging Studies: Packaging Performance Over Shelf Life Aging Studies: Packaging Performance Over Shelf Life In the pharmaceutical industry, the integrity and safety of drug products are deeply intertwined with packaging performance. As medications are subjected to various environmental conditions over time, aging studies are needed to ensure that packaging systems maintain their integrity throughout the product’s shelf life. This guideline…
Freeze-Thaw and Distribution Stresses: CCI After Abuse Freeze-Thaw and Distribution Stresses: CCI After Abuse Understanding the implications of freeze-thaw cycles and distribution stresses on container closure integrity (CCI) is critical for every pharmaceutical professional involved in the validation of packaging systems. This tutorial will guide you through a comprehensive process for assessing the impact of these stressors on CCI, with…
Microbial Ingress Risk: Linking CCI to Sterility Assurance In the pharmaceutical industry, ensuring the sterility of drug products is of paramount importance. With the rise of single-use systems and complex packaging, understanding the link between container closure integrity (CCI) and sterility assurance has become crucial in maintaining compliance with regulatory standards set forth by agencies such as the US FDA,…